« Back
Home /
BMS986020

BMS986020

Item no.	TMO-T4016-2mg
Manufacturer	TargetMol
CASRN	1257213-50-5
Amount	2mg
Category	Oncology Reagents & Chemicals Molecules By Organ Testicular & Prostate Cancer
Type	Molecules
Specific against	other
Citations	1.Kihara Y et al. Lysophospholipid receptors in drug discovery. Exp Cell Res. 2015 May 1;333(2):171-7.
Smiles	CC1=NOC(=C1NC(=O)O[CH](C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Available
Bioactivity	BMS-986020 is an LPA1 antagonist. target: LPA1 BMS-986020 is in Phase 2 clinical development for treating idiopathic pulmonary fibrosis. BMS-986020 selectively inhibits the LPA receptor, which is involved in binding of the signaling molecule lysophosphatidic acid, which in turn is involved in a host of diverse biological functions, such as cell proliferation, platelet aggregation, smooth muscle contraction and others.
MolWt	482, 53
Pathways	GPCR/G Protein
Receptor	LPA1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 2mg

available

Delivery expected until 8/30/2024

Express Delivery: Save 1 days

Compare

Add to wishlist

Recommend by mail